N-Acetyl Cystein and Contrast Nephropathy

Clinical trial NCT01820195 · UNKNOWN

Trial details

NCT number: NCT01820195
Sponsor: Imam Khomeini Hospital
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease Stage 2 Radiographic Contrast Agent Nephropathy

Start date: 2013-03-01
Primary completion: 2014-08-01
Enrollment: 549

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.